Patients were additionally required to have 1 of the following based on data from the 1-year baseline period or the index date: 1 International Classification of Diseases, Tenth Revision (ICD-10) diagnosis code or electronic medical record indicating overweight (BMI of 2529.9 kg/m) with 1 obesity-related complication (identified through ICD-10 diagnosis codes) or 1 ICD-10 diagnosis code or electronic medical record indicating obesity (BMI 30 kg/m 2
Its essentially branded hydration, not an energy product
Additionally, the appetite-suppressing effects of semaglutide often lead to reduced food and fluid intake, further contributing to constipation risk
Ongoing monthly costs vary based on these factors and program duration, with multi-month commitments often offering discounted rates compared to month-to-month enrollment
Serious adverse events remain uncommon in non-diabetic populations using semaglutide for weight loss alone, though individual medical histories, concomitant medications, and baseline health conditions always require provider evaluation